Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Market Cap	6.92B +39.5%
Revenue (ttm)	1.17B +26.9%
Net Income	313.93M +116.0%
EPS	0.82 +112.3%
Shares Out	382.19M
PE Ratio	13.21
Forward PE	10.55
Dividend	0.41 (3.83%)
Ex-Dividend Date	May 28, 2026

Volume	1,627,000
Average Volume	1,159,500
Open	10.81
Previous Close	10.81
Day's Range	10.62 - 11.40
52-Week Range	8.99 - 20.82
Beta	-0.19
RSI	42.57
Earnings Date	Apr 29, 2026

About HKG:1858

Beijing Chunlizhengda Medical Instruments Co., Ltd. engages in the research and development, production, and trading of surgical implants, instruments, and related products in the People’s Republic of China. The company offers implantable orthopedic medical devices, joints, dentures, spine, sports medicine, trauma and orthopedic surgical instruments. It sells its products through distributors, or on ODM and OEM bases, as well as to hospitals directly. It also exports its products. Beijing Chunlizhengda Medical Instruments Co., Ltd. was incorpor...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 1,078
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1858

Financial Performance

In 2025, HKG:1858's revenue was 1.05 billion, an increase of 29.77% compared to the previous year's 805.86 million. Earnings were 272.54 million, an increase of 118.05%.

Financial numbers in CNY